Journal of Cardiothoracic Surgery

FEBRUARY 9, 2024

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

Congenital Heart Disease 52

Congenital Heart Disease Heart Transplant Transplant Congenital 52

Cardiovascular Diabetology

JUNE 20, 2024

Pretransplant type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular and all-cause mortality after heart transplant (HT), but the underlying causes of this association remain unclear.

Heart Transplant 52

Heart Transplant Transplant Diabetes Research 52

Science Daily - Heart Disease

JUNE 10, 2024

Having explored how the heart is formed in utero, a researcher is reporting how cells and molecules act during that early formation and what might cause the heart disease called left ventricular non-compaction or spongy heart, for which patients often require heart transplants.

Heart Disease 91

Heart Disease Heart Transplant Transplant Research 91

Med Page Today

FEBRUARY 13, 2024

(MedPage Today) -- To more fairly rank candidates for heart transplant, researchers developed the U.S. candidate risk score (US-CRS) and found it to better discriminate risk for people with advanced heart failure than the current six-status system.

Heart Transplant 65

Heart Transplant Transplant Heart Failure Research 65

DAIC

FEBRUARY 21, 2024

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Cardiology Update

APRIL 25, 2024

RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

DAIC

APRIL 30, 2024

Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart attacks 105

Heart 2023 Conference

JANUARY 17, 2024

Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute. This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. All rights reserved. 4 Fine, N.

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

DAIC

FEBRUARY 22, 2024

Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104

Journal of Cardiothoracic Surgery

FEBRUARY 15, 2024

This study investigates the efficacy of using a long-acting insulin analog, along with the infusion of regular insulin, in achieving appropriate glycemic control and correcting lactic acidosis in patients post.

Heart Transplant 52

Heart Transplant Transplant Research 52

Cardiology Update

JANUARY 22, 2024

The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. At a mean (±SD) follow-up of 40±20 months, CRT showed a significantly lower risk of death or hospitalization due to heart failure.

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

DAIC

DECEMBER 8, 2023

The study also includes a registry for advanced heart failure patients who are end stage and not considered to be surgical candidates for a heart transplant or left ventricular assist device (LVAD) implant due to excessive fluid retention and poor kidney function. Fain, MD , President and Chief Executive Officer, Procyrion. "We

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

DAIC

APRIL 16, 2024

William Abraham of the Ohio State Wexner College of Medicine presented analysis showing that patients in the trial with Barostim + GDMT had a 74% reduced risk of receiving advanced heart failure interventions (transplant, LVAD, CCM, CRT or CardioMEMS) at long-term follow-up versus patients on GDMT alone. See more details at TCTMD.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

European Journal of Heart Failure

DECEMBER 13, 2023

CV, cardiovascular; HT, heart transplantation; ICU, intensive care unit; LVAD, left ventricular assist device. The primary endpoint was the rate of weaning from VA-ECMO during index admission. The early LV unloading strategy did not increase the weaning rate from VA-ECMO compared with the conventional approach.

Aortic valve 75

Aortic valve Cardiac Arrest Heart Transplant Pulmonary 75

DAIC

MARCH 13, 2024

The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by CMS for both treatment and control procedures. The study includes an eligibility requirement that patients demonstrate a pre-specified NT-proBNP level at baseline.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

With her fellowship, Dr. Fiedler plans to learn skills and administrative approaches that will help her expand the heart transplant program at UW-Madison, where she currently serves as associate director of heart transplantation and mechanical circulatory support. For more information, visit sts.org.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

Open Heart

MAY 25, 2022

The secondary outcome was the TE and mortality and heart transplantation rates between paediatric and adult patients with LVNC. Studies that did not present original research, non-human studies, duplicated studies were excluded. Methods The primary outcome was the prevalence and incidence of TE in the patients with LVNC.

Heart Transplant 40

Heart Transplant Transplant Risk Factors Outcomes 40

European Journal of Heart Failure

NOVEMBER 9, 2023

The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. Multivariable Cox regression and propensity score matching (PSM) analyses were performed.

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

European Journal of Heart Failure

NOVEMBER 7, 2023

The composite endpoint consisted of all-cause mortality, aborted sudden cardiac death, major ventricular arrhythmic events, heart failure hospitalization and heart transplantation. A total of 319 CS patients were studied (67% male, 55.4 ± 12 years). During a median follow-up of 2.2 years

Sudden Cardiac Death 40

Sudden Cardiac Death Outcomes Heart Transplant Heart Failure 40

European Journal of Heart Failure

OCTOBER 3, 2023

CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation. Abstract Aims Improvement of left ventricular ejection fraction is a major goal of heart failure (HF) treatment. Events per 1000 person-years. # ml/min, peak oxygen uptake 62.2

Heart Failure 40

Heart Failure Exercise Laboratory Transplant 40

MIBHS

SEPTEMBER 30, 2024

Open-Heart Surgery : In cases where catheterization is not sufficient, open-heart surgery may be required to repair the defect. This involves opening the chest and heart to make the necessary repairs. Heart Transplant : In the most severe cases, where the heart is too damaged to be repaired, a heart transplant may be necessary.

Congenital 52

Congenital Education Open-Heart Surgery Pediatrics 52

DAIC

FEBRUARY 13, 2024

THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. The research, led by esteemed physician-scientist at The Texas Heart Institute ( THI ), Dr. James F.

Transplant 111

Transplant Pediatrics Heart Transplant Research 111

European Journal of Heart Failure

DECEMBER 13, 2023

For the global rank score all participants were ranked across three hierarchical groups: Tier 1 = time to death or urgent heart transplantation or implantation of a ventricular assist device; Tier 2 = time to non-fatal HF requiring i.v.

Heart Failure 40

Heart Failure COVID-19 Hospital Heart Transplant 40

DAIC

APRIL 8, 2024

Researchers randomly assigned patients to receive standard care or standard care plus treatment with an Impella CP pump. of those who received the Impella pump had died at six months after randomization; there was a 13 percentage point absolute reduction in the rate of death, the study’s primary endpoint, in favor of the heart pump.

Heart attacks 52

Heart attacks Heart Attack Cardiogenic Shock Catheterization Laboratory 52

Circulation: Heart Failure

FEBRUARY 20, 2024

Circulation: Heart Failure, Ahead of Print. Background:Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. The incidence of AR was higher in Black patients compared with White patients (43% versus 19%;P=0.002). 5.04];P=0.004) and %dd-cfDNA (hazard ratio, 1.15 [95% CI, 1.03–1.28];P=0.010)

Heart Transplant 40

Heart Transplant Transplant Heart Failure Outcomes 40

Dr. Anish Koka

JUNE 5, 2023

While US public health authorities have been convinced from the very beginning about how safe and effective the new vaccines are, researchers in other countries with far smaller budgets have been testing that theory. This identified eight cases of sudden cardiac death as caused by VRM that were not known until the autopsy was performed. .

COVID-19 52

COVID-19 Sudden Cardiac Death Public Health Pericarditis 52

European Journal of Heart Failure

DECEMBER 13, 2023

Abstract Aims There is uncertainty about the definition of iron deficiency (ID) and the association between ID and prognosis in patients with advanced heart failure. We evaluated three definitions of ID in patients referred for heart transplantation.

Heart Failure 40

Heart Failure Heart Transplant Transplant Pulmonary 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

DAIC

APRIL 6, 2024

While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

DAIC

APRIL 6, 2024

While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.

Heart Failure 98

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 98

Cardiology Update

APRIL 9, 2024

The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. The primary superiority endpoint was clinically relevant bleeding (Bleeding Academic Research Consortium [known as BARC] types 2, 3, or 5).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Cardiometabolic Health Congress

MARCH 8, 2024

There is increased cognizance of gender inequality and the importance of inclusive and diverse approaches to medical research. Historically, women have been underrepresented in scientific fields, and this spills over into the research and study of women’s health.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59